103
subject
prick
score
group
cytokine
ifn-γ
par
method
test
individual
level
tree
tgf-β
analysis
NSS
ar
elisa
symptom
approaches.il-10
correlation
il-35
sensitivity
treatment
study
role
subgroup
gender
skin
rhinitis
cell
nss
result
duration
literature
total
il-22
patient
sensitization
severity
sar
il-17
control
target
p
r
immunopathogenesis
t
information
clinic
serum
age

37
include
think
compare
be
participate
nss.accompanied
aim
use
detect
research
prick
measure
relate
form
conduct
have
demonstrate
evaluate
make
